UK competition watchdog invites comments on Warner Bros Paramount deal
(Alliance News) - The UK Competition & Markets Authority on Monday invited comments on the acquisition of Warner Bros Discovery Inc by Paramount Skydance Corp. Read More
(Alliance News) - The UK Competition & Markets Authority on Monday invited comments on the acquisition of Warner Bros Discovery Inc by Paramount Skydance Corp. Read More
(Alliance News) - MTI Wireless Edge Ltd on Monday said it has won a USD2.0 million contract with an unnamed local defence company to supply military antennas. Read More
(Alliance News) - The rise in fuel prices in the UK since the start of the Middle East conflict has nearly reached a standstill, new figures show. Read More
(Alliance News) - The head of Energy UK has said it is inevitable that the next price cap update will see bills rise, as a think tank warned the Iran war could make UK households hundreds of pounds worse off. Read More
(Alliance News) - The development of the UK's first mini nuclear reactors is moving forward after Government-owned firm Great British Energy – Nuclear [GBEN] signed a landmark contract with the developers, ministers said. Read More
<p>(Alliance News) - EKF Diagnostics Holdings PLC on Monday said it has inked an agreement to acquire technology assets from Kiruna, Sweden-based Beep Insights AB as it looks to strengthen its Sports Performance products range. <br /><br />The Cardiff, Wales-based diagnostics and biotechnology company said the asset purchase agreement is in relation to the company's Beep Insights Technology. This, said EKF, is an application that combines data from sports performance wearables connected through Bluetooth, with real-time glucose and lactate tracking. <br /><br />As such, said EKF, it is able to provide personalised metrics to improve sports performance training. EKF said the acquisition will support its Lactate Scout Sport product, which it noted is compatible with the Beep Insights application<br /><br />EKF added that Beep Insights Chief Executive Peter Alex is set to join the EKF team following the asset purchase, looking into the development of AI within performance training. <br /><br />The financial terms of the acquisition were not disclosed. <br /><br />Shares in EKF were down 2.6% at 23.58 pence on Monday afternoon in London. <br /><br />EKF CEO Gavin Jones said: "Whilst working with Beep Insights we have been highly impressed with how well their data handling application seamlessly connects with our handheld Lactate Scout Sport device, enabling, fast and accurate lactate threshold testing for sports performance athletes at all levels.<br /><br />"The acquisition of this technology is an exciting step forward for EKF's Sports Performance division as we look to enable athletes of all abilities access to data to drive improved training outcomes."<br /><br />By Christopher Ward, Alliance News reporter<br /><br />Comments and questions to [email protected]<br /><br />Copyright 2026 Alliance News Ltd. All Rights Reserved.</p> Read More
(Alliance News) - Stock prices in London were lower at midday Monday, as rising geopolitical tensions and a renewed surge in oil prices unsettled investors following the collapse of US-Iran peace talks. Read More
(Alliance News) - Concurrent Technologies PLC on Monday said it expects to meet market expectations for 2026, as it posted advances in its top and bottom lines for 2025. Read More
(Alliance News) - Custodian Property Income REIT PLC on Monday said that its recently acquired Grove Court portfolio has performed in line with expectations. Read More
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More
(Alliance News) - EDX Medical Group PLC on Monday shared plans to move its listing to London's AIM from the Aquis Exchange, alongside expectations of "record" revenue in financial 2026. Read More
(Alliance News) - Trellus Health PLC on Monday said it signed a renewal of its licensing agreement with New York-based pharmaceutical company Pfizer Inc. Read More